Lynx1 Capital Management’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.1M | Buy |
4,400,842
+1,185,120
| +37% | +$8.92M | 9.57% | 5 |
|
|
2025
Q1 | $24.3M | Buy |
3,215,722
+1,957,927
| +156% | +$14.8M | 8.72% | 5 |
|
|
2024
Q4 | $15.3M | Buy |
1,257,795
+846,965
| +206% | +$10.3M | 5.74% | 7 |
|
|
2024
Q3 | $6.88M | Buy |
410,830
+33,507
| +9% | +$561K | 2.44% | 7 |
|
|
2024
Q2 | $6.58M | Buy |
+377,323
| New | +$6.58M | 2.37% | 6 |
|
|
2023
Q3 | – | Sell |
-115,063
| Closed | -$1.24M | – | 20 |
|
|
2023
Q2 | $1.24M | Buy |
+115,063
| New | +$1.24M | 0.81% | 12 |
|